POLICY STATEMENT
Endorsement of Health and Human Services Recommendation for Pulse Oximetry Screening for Critical Congenital Heart Disease abstract Incorporation of pulse oximetry to the assessment of the newborn infant can enhance detection of critical congenital heart disease (CCHD). Recently, the Secretary of Health and Human Services (HHS) recommended that screening for CCHD be added to the uniform screening panel. The American Academy of Pediatrics (AAP) has been a strong advocate of early detection of CCHD and fully supports the decision of the Secretary of HHS.
The AAP has published strategies for the implementation of pulse oximetry screening, which addressed critical issues such as necessary equipment, personnel, and training, and also provided specific recommendations for assessment of saturation by using pulse oximetry as well as appropriate management of a positive screening result. The AAP is committed to the safe and effective implementation of pulse oximetry screening and is working with other advocacy groups and governmental agencies to promote pulse oximetry and to support widespread surveillance for CCHD.
Going forward, AAP chapters will partner with state health departments to implement the new screening strategy for CCHD and will work to ensure that there is an adequate system for referral for echocardiographic/pediatric cardiac evaluation after a positive screening result. It is imperative that AAP members engage their respective policy makers in adopting and funding the recommendations made by the Secretary of HHS. Pediatrics 2012; 129:190-192 Delayed diagnosis of critical congenital heart disease (CCHD) can result in death or injury to infants. The current approach to detect CCHD in the United States relies on prenatal ultrasound examinations and the physical examination findings in the newborn nursery. Unfortunately, this approach fails to identify a significant number of cases of CCHD, which may lead to late diagnosis with significant morbidity, permanent injury of vital organs, and in some cases, death. A number of studies have revealed that adding pulse oximetry to the assessment of the newborn can enhance detection of CCHD. Pulse oximetry is a readily available, noninvasive, and painless technology that can be incorporated into the routine assessment of the newborn. In the event of a positive screening result, CCHD needs to be excluded with a diagnostic echocardiogram. Infectious and pulmonary causes of hypoxemia should also be excluded.
The AAP can play an important role in assuring the safe and effective implementation of screening for CCHD. This includes preparing members to implement screening; engaging pediatricians to participate in qualityimprovement activities to ensure that newborn infants are appropriately screened with follow-up echocardiograms and specialty care, as required; partnering with public health agencies for surveillance of CCHD; and advocating for appropriate payment for all screening-related activities. In addition to promoting the implementation of pulse oximetry based screening programs, the AAP supports widespread surveillance for CCHD. Such surveillance will yield several benefits, including documentation of any improvement in detection as well as identification of areas of weakness for this comprehensive screening strategy.
Although the Secretary of HHS has recommended that screening for CCHD be added to the RUSP, it will be up to states to determine how they wish to incorporate this into their own screening programs. This may be accomplished by legislation, regulation, or adoption as a standard of practice. The majority of disorders identified on the RUSP are adopted by most states, but there is variability among the states. A number of states have already incorporated routine screening for CCHD into the statewide panel. These states can serve as a paradigm for subsequent implementation by other states.* It will be critical that AAP chapters work with state health departments to implement the new screening strategy for CCHD in a manner that is adequately financed, cost-effective, and practical; that ensures screening and for echocardiographic/pediatric cardiac evaluation and therapeutic intervention as indicated with provision for follow-up for all newborn infants within the framework of the medical home; and that ensures that related payment issues for technical and professional services are addressed. It is hoped that through these collaborative efforts, the burden of delayed diagnosis of congenital heart disease will be reduced and the health of children will be enhanced for years to come. 
